BIO CEO and Investor Conference to Webcast Alkermes' Corporate Presentation.Business Editors and Health/Medical Writers CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 20, 2002 Alkermes, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : ALKS ALKS Alkermes, Inc. (stock symbol) ) announced today that its corporate presentation will be webcast live by The Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
The process by which the corporation communicates with its investors. tab at www.alkermes.com. Richard Pops, Chief Executive Officer of Alkermes, Inc., will present an overview of the company at 8:10am ET on Thursday, February 21, 2002, from The Waldorf Astoria Hotel in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of . Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. We have several areas of focus, including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks, using our ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on our proprietary AIR(TM) pulmonary technology. In addition to our Cambridge, Massachusetts, headquarters, research and manufacturing facilities, Alkermes operates research and manufacturing facilities in Ohio and a medical affairs office in Cambridge, England. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion